Flexion Therapeutics

208 articles about Flexion Therapeutics

• Flexion Therapeutics Names Frederick Driscoll Chief Financial Officer

  5/20/2013

• Data Presented at OARSI's 2013 World Congress on Osteoarthritis Show Flexion Therapeutics's FX006 Has Prolonged Therapeutic Concentration in Knee Joint

  4/19/2013

• Flexion Therapeutics to Present at 31st Annual J.P. Morgan Healthcare Conference

  1/4/2013

• Flexion Therapeutics's FX006 Achieves Prolonged Therapeutic Concentrations in Joints of Osteoarthritis Patients

  12/17/2012

• Flexion Therapeutics Names Arthur Fratamico Chief Business Officer

  6/20/2012

• Flexion Therapeutics Reports Positive Data for Osteoarthritis Drug

  5/31/2012

• Flexion Therapeutics Announces Agreements with Four Major Pharmaceutical Companies Such As AstraZeneca PLC (JOBS) And Merck Serono (JOBS); Closes Series A Financing Round At $42 Million

  1/29/2010

• Flexion Therapeutics Raises $33 Million in Series A Financing

  10/19/2009